| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 134, 2397-2403, Copyright © 1994 by Endocrine Society
ARTICLES |
MM Ilondo, AB Damholt, BA Cunningham, JA Wells, P De Meyts and RM Shymko
Hagedorn Research Institute, Gentofte, Denmark.
Binding of GH to its cell surface receptors is thought to result in the formation of a complex comprised of one molecule of hormone per two molecules of receptor. It has been proposed that this hormone-induced receptor dimerization is important for the mechanism of signal transduction. We have developed a mathematical model for quantitative evaluation of the biological responses associated with sequential receptor dimerization. Based on these predictions, we have investigated whether GH-induced receptor dimerization plays a role in two classical effects of GH, i.e. stimulation of lipogenesis in primary rat adipocytes and GH receptor down-regulation in cultured human IM-9 lymphocytes. Model predictions of biological responses linked to dimer formation yielded a bell-shaped pattern, with self-antagonism at high GH concentrations when monomeric GH-receptor complexes become predominant. The GH lipogenic bioactivity curve was indeed biphasic and first increased in a concentration-dependent manner between 10(-10)-10(- 8) M GH (ED50, 0.5 nM), up to a maximum of 1.7-fold stimulation above basal. Then, the response decreased continuously above 5 x 10(-8) M GH, returning to basal levels around 10(-5) M GH. Incubation of IM-9 cells with wild-type human GH resulted in a dose-dependent loss of their surface receptors. In contrast, a human GH analog (G120R), mutated in the second binding surface of the hormone and, therefore, unable to induce GH receptor dimerization, failed to induce receptor down- regulation in the IM-9 cells. Furthermore, when added together with wild-type human GH, human GH(G120R) inhibited, in a concentration- dependent manner, the down-regulation induced by wild-type human GH. Taken together, these data support the hypothesis that receptor dimerization is critical for the stimulation by GH of both lipogenesis in primary rat adipocytes and receptor down-regulation in cultured human IM-9 lymphocytes.
This article has been cited by other articles:
![]() |
C. E. Higham and P. J. Trainer Growth hormone excess and the development of growth hormone receptor antagonists Exp Physiol, November 1, 2008; 93(11): 1157 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Jantarajit, N. Thongon, J. Pandaranandaka, J. Teerapornpuntakit, N. Krishnamra, and N. Charoenphandhu Prolactin-stimulated transepithelial calcium transport in duodenum and Caco-2 monolayer are mediated by the phosphoinositide 3-kinase pathway Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E372 - E384. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wan, A. McDevitt, B. Shen, M. L. Smythe, and M. J. Waters Increased Site 1 Affinity Improves Biopotency of Porcine Growth Hormone: EVIDENCE AGAINST DIFFUSION DEPENDENT RECEPTOR DIMERIZATION J. Biol. Chem., October 22, 2004; 279(43): 44775 - 44784. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhou, W. K. W. Ko, W. K. K. Ho, S. S. Stojilkovic, and A. O. L. Wong Novel Aspects of Growth Hormone (GH) Autoregulation: GH-Induced GH Gene Expression in Grass Carp Pituitary Cells through Autocrine/Paracrine Mechanisms Endocrinology, October 1, 2004; 145(10): 4615 - 4628. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. O'Leary and R. A. Hughes Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor J. Biol. Chem., July 3, 2003; 278(28): 25738 - 25744. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M. Duda and C.L. Brooks Differential effects of zinc on functionally distinct human growth hormone mutations Protein Eng. Des. Sel., July 1, 2003; 16(7): 531 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Duda and C. L. Brooks Identification of Residues Outside the Two Binding Sites That Are Critical for Activation of the Lactogenic Activity of Human Growth Hormone J. Biol. Chem., June 13, 2003; 278(25): 22734 - 22739. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. van Kerkhof, M. Smeets, and G. J. Strous The Ubiquitin-Proteasome Pathway Regulates the Availability of the GH Receptor Endocrinology, April 1, 2002; 143(4): 1243 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bernichtein, S. Kinet, S. Jeay, M. Llovera, D. Madern, J. A. Martial, P. A. Kelly, and V. Goffin S179D-Human PRL, a Pseudophosphorylated Human PRL Analog, Is an Agonist and Not an Antagonist Endocrinology, September 1, 2001; 142(9): 3950 - 3963. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Behncken, N. Billestrup, R. Brown, J. Amstrup, B. Conway-Campbell, and M. J. Waters Growth Hormone (GH)-independent Dimerization of GH Receptor by a Leucine Zipper Results in Constitutive Activation J. Biol. Chem., May 26, 2000; 275(22): 17000 - 17007. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. SEGEV, D. LANDAU, R. RASCH, A. FLYVBJERG, and M. PHILLIP Growth Hormone Receptor Antagonism Prevents Early Renal in Nonobese Diabetic Mice J. Am. Soc. Nephrol., November 1, 1999; 10(11): 2374 - 2381. [Abstract] [Full Text] |
||||
![]() |
S. Kinet, S. Bernichtein, P. A. Kelly, J. A. Martial, and V. Goffin Biological Properties of Human Prolactin Analogs Depend Not Only on Global Hormone Affinity, but Also on the Relative Affinities of Both Receptor Binding Sites J. Biol. Chem., September 10, 1999; 274(37): 26033 - 26043. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Juarez-Aguilar, F Castro-Munozledo, N. Guerra-Rodriguez, D Resendez-Perez, H. Martinez-Rodriguez, H. Barrera-Saldana, and W Kuri-Harcuch Functional domains of human growth hormone necessary for the adipogenic activity of hGH/hPL chimeric molecules J. Cell Sci., January 9, 1999; 112(18): 3127 - 3135. [Abstract] [PDF] |
||||
![]() |
T. Amit, O. Bar-Am, F. Dastot, M. B. H. Youdim, S. Amselem, and Z.'e. Hochberg The Human Growth Hormone (GH) Receptor and Its Truncated Isoform: Sulfhydryl Group Inactivation in the Study of Receptor Internalization and GH-Binding Protein Generation Endocrinology, January 1, 1999; 140(1): 266 - 272. [Abstract] [Full Text] |
||||
![]() |
A. Whitty, N. Raskin, D. L. Olson, C. W. Borysenko, C. M. Ambrose, C. D. Benjamin, and L. C. Burkly Interaction affinity between cytokine receptor components on the cell surface PNAS, October 27, 1998; 95(22): 13165 - 13170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Le Stunff and P. Rotwein Growth Hormone Stimulates Interferon Regulatory Factor-1 Gene Expression in the Liver Endocrinology, March 1, 1998; 139(3): 859 - 866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wada, H. Uchida, M. Ikeda, B. Tsunekawa, N. Naito, S. Banba, E. Tanaka, Y. Hashimoto, and M. Honjo The 20-Kilodalton (kDa) Human Growth Hormone (hGH) Differs from the 22-kDa hGH in the Complex Formation with Cell Surface hGH Receptor and hGH-Binding Protein Circulating in Human Plasma Mol. Endocrinol., January 1, 1998; 12(1): 146 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Kalloo-Hosein, J. P. Whitehead, M. Soos, J. M. Tavare, K. Siddle, and S. O'Rahilly Differential Signaling to Glycogen Synthesis by the Intracellular Domain of the Insulin versus the Insulin-like Growth Factor-1 Receptor. EVIDENCE FROM STUDIES OF TrkC-CHIMERAS J. Biol. Chem., September 26, 1997; 272(39): 24325 - 24332. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. I. Ymer, J. L. Stevenson, and A. C. Herington Guinea Pig Serum Contains a Specific High Affinity Growth Hormone-Binding Protein with Novel Ligand Specificity Endocrinology, September 1, 1997; 138(9): 3577 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, R. Brinkworth, and M. J. Waters The Role of Receptor Dimerization Domain Residues in Growth Hormone Signaling J. Biol. Chem., February 21, 1997; 272(8): 5133 - 5140. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Clark, K. Olson, G. Fuh, M. Marian, D. Mortensen, G. Teshima, S. Chang, H. Chu, V. Mukku, E. Canova-Davis, et al. Long-acting Growth Hormones Produced by Conjugation with Polyethylene Glycol J. Biol. Chem., September 6, 1996; 271(36): 21969 - 21977. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Goffin, S. Kinet, F. Ferrag, N. Binart, J. A. Martial, and P. A. Kelly Antagonistic Properties of Human Prolactin Analogs That Show Paradoxical Agonistic Activity in the Nb2 Bioassay J. Biol. Chem., July 12, 1996; 271(28): 16573 - 16579. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Harding, X. Wang, S. Okada, W. Y. Chen, W. Wan, and J. J. Kopchick Growth Hormone (GH) and a GH Antagonist Promote GH Receptor Dimerization and Internalization J. Biol. Chem., March 22, 1996; 271(12): 6708 - 6712. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Rowlinson, R. Barnard, S. Bastiras, A. J. Robins, R. Brinkworth, and M. J. Waters A Growth Hormone Agonist Produced by Targeted Mutagenesis at Binding Site 1 J. Biol. Chem., July 14, 1995; 270(28): 16833 - 16839. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Zioncheck, L. Richardson, J. Liu, L. Chang, K. L. King, G. L. Bennett, Pèt. Fügedi, S. M. Chamow, R. H. Schwall, and R. J. Stack Sulfated Oligosaccharides Promote Hepatocyte Growth Factor Association and Govern Its Mitogenic Activity J. Biol. Chem., July 14, 1995; 270(28): 16871 - 16878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Dattani, P. C. Hindmarsh, C. G. D. Brook, I. C. A. F. Robinson, J. J. Kopchick, and N. J. Marshall G120R, a Human Growth Hormone Antagonist, Shows Zinc-dependent Agonist and Antagonist Activity on Nb2 Cells J. Biol. Chem., April 21, 1995; 270(16): 9222 - 9226. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ridderstråle, E. Degerman, and H. Tornqvist Growth Hormone Stimulates the Tyrosine Phosphorylation of the Insulin Receptor Substrate-1 and Its Association with Phosphatidylinositol 3-Kinase in Primary Adipocytes J. Biol. Chem., February 24, 1995; 270(8): 3471 - 3474. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Tsunekawa, M. Wada, M. Ikeda, S. Banba, H. Kamachi, E. Tanaka, and M. Honjo The Binding between the Stem Regions of Human Growth Hormone (GH) Receptor Compensates for the Weaker Site 1 Binding of 20-kDa Human GH (hGH) than That of 22-kDa hGH J. Biol. Chem., May 19, 2000; 275(21): 15652 - 15656. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |